Yoshie Sakamaki
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Researcher
Faculty Researcher
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Yoshie Sakamaki's research focuses on the development and application of novel compounds for cancer therapy. Her work involves the synthesis of organometallic complexes and nanostructures for targeted drug delivery, particularly in photodynamic therapy. Recent publications highlight the investigation of bioconjugated chlorin-based metal–organic frameworks for treating triple-negative breast and pancreatic cancers. Additionally, her research explores luminescent heterobimetallic PtII–AuI complexes as potential anticancer agents. Sakamaki has a publication record of 20 papers with 232 citations and an h-index of 8. She collaborates with researchers at the University of Arkansas at Fayetteville, including M. Hassan Beyzavi, Jin-Woo Kim, Yuchun Du, and Zachary McConnell.
Metrics
- h-index: 8
- Publications: 20
- Citations: 242
Selected Publications
-
Luminescent Heterobimetallic Pt<sup>II</sup>–Au<sup>I</sup> Complexes Bearing <i>N</i>-Heterocyclic Carbenes (NHCs) as Potent Anticancer Agents (2023)
-
A Bioconjugated Chlorin-Based Metal–Organic Framework for Targeted Photodynamic Therapy of Triple Negative Breast and Pancreatic Cancers (2021)
-
Fluorinated Cycloplatinated(II) Complexes Bearing Bisphosphine Ligands as Potent Anticancer Agents (2020)
-
A C^N Cycloplatinated(II) Fluoride Complex: Photophysical Studies and C <sub> sp <sup>3</sup> </sub> –F Bond Formation (2020)
-
Using a Faculty-Developed Documentary-Style Film to Communicate Authentic Chemistry Research to a High School Audience (2020)
-
Maltotriose Conjugated Metal–Organic Frameworks for Selective Targeting and Photodynamic Therapy of Triple Negative Breast Cancer Cells and Tumor Associated Macrophages (2020)
-
Preparation and Applications of Metal–Organic Frameworks (MOFs): A Laboratory Activity and Demonstration for High School and/or Undergraduate Students (2020)
-
trans‐Platinum(II) Thionate Complexes: Synthesis, Structural Characterization, and in vitro Biological Assessment as Potent Anticancer Agents (2019)
-
Metal–Organic Frameworks and Covalent Organic Frameworks as Platforms for Photodynamic Therapy (2018)
-
Micro-flow nanocatalysis: synergic effect of TfOH@SPIONs and micro-flow technology as an efficient and robust catalytic system for the synthesis of plasticizers (2018)
Collaboration Network
Top Collaborators
- A Bioconjugated Chlorin-Based Metal–Organic Framework for Targeted Photodynamic Therapy of Triple Negative Breast and Pancreatic Cancers
- Luminescent Heterobimetallic Pt<sup>II</sup>–Au<sup>I</sup> Complexes Bearing <i>N</i>-Heterocyclic Carbenes (NHCs) as Potent Anticancer Agents
- A Bioconjugated Chlorin-Based Metal–Organic Framework for Targeted Photodynamic Therapy of Triple Negative Breast and Pancreatic Cancers
- A Bioconjugated Chlorin-Based Metal–Organic Framework for Targeted Photodynamic Therapy of Triple Negative Breast and Pancreatic Cancers
- A Bioconjugated Chlorin-Based Metal–Organic Framework for Targeted Photodynamic Therapy of Triple Negative Breast and Pancreatic Cancers
- A Bioconjugated Chlorin-Based Metal–Organic Framework for Targeted Photodynamic Therapy of Triple Negative Breast and Pancreatic Cancers
- A Bioconjugated Chlorin-Based Metal–Organic Framework for Targeted Photodynamic Therapy of Triple Negative Breast and Pancreatic Cancers
- A Bioconjugated Chlorin-Based Metal–Organic Framework for Targeted Photodynamic Therapy of Triple Negative Breast and Pancreatic Cancers
- A Bioconjugated Chlorin-Based Metal–Organic Framework for Targeted Photodynamic Therapy of Triple Negative Breast and Pancreatic Cancers
- A Bioconjugated Chlorin-Based Metal–Organic Framework for Targeted Photodynamic Therapy of Triple Negative Breast and Pancreatic Cancers
- A Bioconjugated Chlorin-Based Metal–Organic Framework for Targeted Photodynamic Therapy of Triple Negative Breast and Pancreatic Cancers
- A Bioconjugated Chlorin-Based Metal–Organic Framework for Targeted Photodynamic Therapy of Triple Negative Breast and Pancreatic Cancers
- A Bioconjugated Chlorin-Based Metal–Organic Framework for Targeted Photodynamic Therapy of Triple Negative Breast and Pancreatic Cancers
- A Bioconjugated Chlorin-Based Metal–Organic Framework for Targeted Photodynamic Therapy of Triple Negative Breast and Pancreatic Cancers
- Luminescent Heterobimetallic Pt<sup>II</sup>–Au<sup>I</sup> Complexes Bearing <i>N</i>-Heterocyclic Carbenes (NHCs) as Potent Anticancer Agents
- Luminescent Heterobimetallic Pt<sup>II</sup>–Au<sup>I</sup> Complexes Bearing <i>N</i>-Heterocyclic Carbenes (NHCs) as Potent Anticancer Agents
Similar Researchers
Based on overlapping research topics